Bayer Highlights Advancements of Agriculture Industry's Most Prolific R&D PipelineBusiness Wire • 02/16/22
Bayer Earns Top Score in 2022 Corporate Equality Index for Fifth Consecutive YearBusiness Wire • 01/27/22
Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy ManufacturingBusiness Wire • 01/25/22
MustGrow and Bayer sign Exclusive Agreement to Develop Sustainable Organic Biologicals in Europe, Asia Pacific, Middle East and AfricaNewsfile Corp • 01/21/22
Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing TechnologyBusiness Wire • 01/10/22
Bayer to Launch Project Carbonview, an Industry-First Digital Carbon Footprint Measurement Solution for AgricultureBusiness Wire • 12/08/21
Phase III Investigational Trial of NUBEQA® (darolutamide) in Combination with Docetaxel and Androgen Deprivation Therapy (ADT) Meets Primary Endpoint of Significantly Increasing Overall Survival (OS) in Patients with mHSPCBusiness Wire • 12/03/21
Bayer Invests €100 million in Sustainable Health Products to Advance Company's 2030 Sustainability CommitmentsBusiness Wire • 12/01/21
Bayer Presented New Analyses Investigating KERENDIA® (finerenone) on Cardiovascular Outcomes in Patients With Chronic Kidney Disease Associated With Type 2 DiabetesBusiness Wire • 11/18/21
Bayer, Microsoft Enter Into Strategic Partnership to Optimize and Advance Digital Capabilities for Food, Feed, Fuel, Fiber Value ChainBusiness Wire • 11/17/21